Dr. Chen is an editor-in-chief of Journal of Cancer Research Updates, and New Developments on Chemistry, an editor of African Journal of Pharmacy and Pharmacology, Regional Editor of Recent Patents on Anticancer Drugs Discovery, a guest editor of Current Pharmaceutical Biotechnology, an editorial board member of more than 20 journals and a reviewer of more than 170 peer reviewed journals. He is also an Ad hoc reviewer of some grants such as NIH, NCI Special Emphasis Review Panel, OmniBus SEP-10, State Grant Reviewer for Louisiana, and grants for New Zealand, Poland, China, Hungary, and Netherlands etc. As a consultant to pharmaceutical, biotechnology and health industry organizations, Dr. Chen commands invitations for presentations, keynote addresses, and conference chairman. He published more than 150 publications in peer reviewed journals and 5 book chapters.

Research Interests
Our primary goal is to develop more effective chemotherapeutic agents for cancer patients. Multidrug resistance (MDR) represents a major obstacle to the treatment of cancer, and understanding the resistance mechanisms and knowing how to reverse the